AI-based prognostic imaging biomarkers for precision neuro-oncology: the ReSPOND consortium. [electronic resource]
- Neuro-oncology 06 2020
- 886-888 p. digital
Publication Type: Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1523-5866
10.1093/neuonc/noaa045 doi
Artificial Intelligence Biomarkers Humans Medical Oncology Precision Medicine Prognosis